Funds holding Cullinan Therapeutics Inc
ISIN US2300311063 · United States
- Fund holders
- 160
- Of which ETFs
- 35 125 other funds
- Value held
- ≈ 181.1M $ 180.9M $ · 250.9K €
- Share of capital
- 19.9 % of 64.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Adara Smaller Companies Fund RBB Fund, Inc. | 6,212 | 96.3K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 5,965 | 84.8K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 5,777 | 75.4K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 5,658 | 80.4K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PGIM Balanced Fund Prudential Investment Portfolios, Inc. | 5,400 | 76.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 5,083 | 66.3K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 4,935 | 76.5K $ | 0.06 % | 0.01 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 4,664 | 72.3K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 4,575 | 65K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 4,305 | 61.2K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 4,225 | 60K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 4,093 | 53.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 4,078 | 53.2K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 3,778 | 53.7K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 3,622 | 51.5K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 3,585 | 50.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 3,347 | 51.9K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 3,338 | 51.7K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,316 | 51.4K $ | 0.07 % | 0.01 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 2,908 | 41.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 2,745 | 39K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,728 | 42.3K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,469 | 35.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 2,412 | 34.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,339 | 36.3K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 2,086 | 32.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,892 | 29.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,806 | 23.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,772 | 23.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,729 | 24.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 1,440 | 18.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,400 | 19.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,309 | 20.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,271 | 18.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,253 | 17.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,216 | 17.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,030 | 14.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 954 | 13.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Next Index ETF RBB Fund, Inc. | 878 | 13.6K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 846 | 11K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 800 | 11.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 660 | 9.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 608 | 7.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 427 | 6.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 413 | 5.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 315 | 4.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 281 | 4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 260 | 3.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 180 | 2.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 177 | 2.7K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 136 | 1.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 120 | 1.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 98 | 1.3K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 72 | 1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 55 | 852.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 37 | 525.8 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 16 | 248 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 14 | 198.9 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 223.1K € | 0.27 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 27.8K € | 0.76 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.81 % | as of Apr 30, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 0.76 % | as of Dec 31, 2025 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 0.73 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 0.46 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.27 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.25 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.24 % | as of Mar 31, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 0.19 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 0.19 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.19 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 158 | +12 | 12,805,433 | +20.7 % |
| 2026Q1 | 146 | +4 | 10,605,277 | +13.9 % |
| 2025Q4 | 142 | +3 | 9,314,673 | -13.9 % |
| 2025Q3 | 139 | -18 | 10,813,489 | -10.9 % |
| 2025Q2 | 157 | -4 | 12,143,111 | -1.9 % |
| 2025Q1 | 161 | -11 | 12,376,041 | -2.0 % |
| 2024Q4 | 172 | +7 | 12,629,973 | +19.8 % |
| 2024Q3 | 165 | +11 | 10,545,603 | +36.6 % |
| 2024Q2 | 154 | +16 | 7,721,891 | +11.5 % |
| 2024Q1 | 138 | -2 | 6,926,897 | +5.0 % |
| 2023Q4 | 140 | 6,595,818 |
Institutional managers
166 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Lynx1 Capital Management LP | 8,963,500 | 127.4M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 7,648,268 | 108.7M $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,750,683 | 81.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,449,966 | 63.2M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 3,114,132 | 44.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,544,115 | 36.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,029,719 | 28.8K $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 1,909,764 | 27.1M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,705,960 | 24.2M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 1,379,965 | 19.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,368,268 | 19.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 1,193,410 | 17M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 1,141,145 | 16.2M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,112,803 | 15.8M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,049,581 | 14.9M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 906,028 | 12.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 905,376 | 12.9M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 805,700 | 11.4M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 781,260 | 11.1M $ | as of Mar 31, 2026 |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 595,489 | 8.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 589,483 | 8.4M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 530,000 | 7.5M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 522,047 | 7.4M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 516,724 | 7.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 455,449 | 6.5M $ | as of Mar 31, 2026 |
Declared shareholders of Cullinan Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.99 % | 6,161,469 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Cullinan Therapeutics Inc". https://titelia.com/en/stocks/cullinan-therapeutics-inc-US2300311063